$2.61
0.06% today
Nasdaq, Apr 03, 06:13 pm CET
ISIN
US45779A8466
Symbol
NSPR

InspireMD Inc Stock price

$2.61
-0.39 13.00% 1M
+0.01 0.39% 6M
-0.02 0.76% YTD
+0.46 21.40% 1Y
-0.57 17.92% 3Y
-6.41 71.05% 5Y
-2,099,997.39 100.00% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
+0.08 2.96%
ISIN
US45779A8466
Symbol
NSPR
Sector

Key metrics

Market capitalization $77.49m
Enterprise Value $45.19m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.45
P/S ratio (TTM) P/S ratio 11.05
P/B ratio (TTM) P/B ratio 1.92
Revenue growth (TTM) Revenue growth 12.96%
Revenue (TTM) Revenue $7.01m
EBIT (operating result TTM) EBIT $-33.50m
Free Cash Flow (TTM) Free Cash Flow $-23.27m
Cash position $34.64m
EPS (TTM) EPS $-0.78
P/S forward 8.75
EV/Sales forward 5.10
Short interest 0.95%
Show more

Is InspireMD Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

InspireMD Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

Buy
100%

Financial data from InspireMD Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
7.01 7.01
13% 13%
100%
- Direct Costs 5.50 5.50
25% 25%
78%
1.51 1.51
17% 17%
22%
- Selling and Administrative Expenses 21 21
43% 43%
301%
- Research and Development Expense 14 14
71% 71%
194%
-33 -33
59% 59%
-474%
- Depreciation and Amortization 0.28 0.28
22% 22%
4%
EBIT (Operating Income) EBIT -34 -34
58% 58%
-478%
Net Profit -32 -32
61% 61%
-457%

In millions USD.

Don't miss a Thing! We will send you all news about InspireMD Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

InspireMD Inc Stock News

Neutral
GlobeNewsWire
8 days ago
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 8:00AM Eastern Time / 5:00AM Pacific Time. A live audio webcast and repl...
Neutral
Seeking Alpha
22 days ago
NSPR (NASDAQ:NSPR ) Q4 2024 Earnings Conference Call March 12, 2025 8:30 AM ET Company Participants Marvin Slosman - CEO Craig Shore - CFO Shane Gleason - CCO Webb Campbell - IR, Gilmartin Group Conference Call Participants Adam Maeder - Piper Sandler Frank Takkinen - Lake Street Capital Markets Richard Nesbitt - InspireMD Operator Hello and welcome to InspireMD's fourth quarter 2024 earnings c...
Neutral
GlobeNewsWire
22 days ago
MIAMI, March 12, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Recent Business Highlights: Engaged with the U.S. Food and Drug Administration (FDA) on the...
More InspireMD Inc News

Company Profile

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Head office United States
CEO Marvin Slosman
Employees 86
Founded 2005
Website www.inspiremd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today